HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Interest & Investment Income (2015 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Interest & Investment Income came in at $1.9 million in Q4 2021, up 280.28% quarter-over-quarter from $492000.0 in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Interest & Investment Income (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Interest & Investment Income for 6 consecutive years, with $1.9 million the latest figure, recorded in Q4 2021.

  • On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $1.9 million in Q4 2021; TTM through Dec 2021 was $3.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $49.9 million, up 24.44% from the prior year.
  • Interest & Investment Income was $1.9 million for Q4 2021 at HUTCHMED (China), up from $492000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.9 million in Q4 2021 and troughed at $196000.0 in Q1 2020.
  • A 4-year average of $1.2 million and a median of $1.4 million in 2019 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income plunged 88.31% in 2020 and jumped 151.02% in 2021, its largest moves.
  • Over 4 years, Interest & Investment Income stood at $1.5 million in 2018, then decreased by 9.06% to $1.4 million in 2019, then tumbled by 85.85% to $196000.0 in 2020, then jumped by 854.59% to $1.9 million in 2021.
  • The last three Interest & Investment Income figures came in at $1.9 million (Q4 2021), $492000.0 (Q1 2021), and $196000.0 (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn -
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn -48.00 Mn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn 48.00 Mn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn 67.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 36.92 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.87 Mn
Mar 31, 2021 492,000.00
Mar 31, 2020 196,000.00
Jun 30, 2019 1.39 Mn
Mar 31, 2019 1.68 Mn
Jun 30, 2018 1.52 Mn
Mar 31, 2018 1.27 Mn
Jun 30, 2016 385,000.00
Jun 30, 2015 379,000.00